Satoshi Kambayashi

Dr. Satoshi Kambayashi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
MIMasaya Igase
Masaya Igase
SISakuya Inanaga
Sakuya Inanaga
SNShoma Nishibori
Shoma Nishibori
KIKazuhito Itamoto
Kazuhito Itamoto
HSHiroshi Sunahara
Hiroshi Sunahara
TMTakuya Mizuno
Takuya Mizuno
Igase M, et al. J Vet Sci. 2024 Jan;25(1):e15. https://doi.org/10.4142/jvs.23144

11 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
KMKanako Matsuse
Kanako Matsuse
HSHirata Sho
Hirata Sho
MOSTAFA ABDELRAHMANMOSTAFA ABDELRAHMAN
MOSTAFA ABDELRAHMAN
TNTetsuya Nakajima
Tetsuya Nakajima
YIYoshihito Iuchi
Yoshihito Iuchi
Masayoshi ShigyoMasayoshi Shigyo
Masayoshi Shigyo
To investigate the bioactivities of fresh garlic and its processed product, black garlic, we conducted comparative analyses of antioxidant, anti-inflammatory, innate immune activation, and anti-cancer activities in addition to the chemical composition (sugar, amino acid, and polyphenol contents) of these materials. Simultaneous assay using neutrophil-like cells showed that fresh garlic exhibited antioxidant and innate immunostimulatory activities, whereas black garlic displayed a potent anti-inflammatory effect. The antioxidant activity index was correlated with phenol and flavonoid contents, while the innate immunostimulatory activity was correlated with fructan content. Furthermore, some black garlics with low fructose content were found to inhibit the proliferation of UM-UC-3 cancer cells, while other black garlics rich in fructose increased UM-UC-3 cell proliferation. It was shown that the processing of fresh garlic could change the composition of sugars, antioxidants, and amino acids, which have different effects on neutrophil-like cells and UM-UC-3 cells, as well as on bioactivities.

29 January 2024 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
SKSatoshi Kambayashi
Satoshi Kambayashi
NONanae Ono
Nanae Ono
TTTomofumi Tone
Tomofumi Tone
KBKenji Baba
Kenji Baba
MOMasaru Okuda
Masaru Okuda

29 July 2022 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
LMLeni Maylina
Leni Maylina
SKSatoshi Kambayashi
Satoshi Kambayashi
KBKenji Baba
Kenji Baba
MOMasaru Okuda
Masaru Okuda
Cyclin-dependent kinase inhibitor p16 (CDKN2A) primarily functions as a negative regulator of the retinoblastoma protein (pRb) pathway to prevent pRb phosphorylation, thus playing a critical role in cell cycle arrest. In canine lymphoma cells, methylation due to inactivation of the p16 gene has been reported. However, its protein expression has not been examined in previous studies. In our in vitro study, the gene and protein expression of p16 and phosphorylated pRb were examined simultaneously in eight canine lymphoma and leukemia cell lines (17-71, CLBL-1, GL-1, CLC, CLGL-90, Ema, Nody-1, and UL-1). Methylation of the p16 gene was also explored using the demethylation drug 5-Aza-2′-deoxycytidine (5-Aza). After 5-Aza treatment, p16 gene and protein expression increased and pRb phosphorylation decreased, suggesting that both hypermethylation of the p16 gene and pRb hyperphosphorylation occurred in four out of eight cell lines (CLBL-1, CLC, Nody-1, and UL-1). Moreover, the estimation of p16’s protein expression was better than that of p16’s mRNA expression because the expression of the protein was more stable than those of the gene, and highly related to the phosphorylation of pRb. These results revealed that p16’s protein expression could be a promising biomarker for canine lymphoma cells.

26 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
KMKanako Matsuse
Kanako Matsuse
HSHirata Sho
Hirata Sho
MOSTAFA ABDELRAHMANMOSTAFA ABDELRAHMAN
MOSTAFA ABDELRAHMAN
TNTetsuya Nakajima
Tetsuya Nakajima
YIYoshihito Iuchi
Yoshihito Iuchi
Masayoshi ShigyoMasayoshi Shigyo
Masayoshi Shigyo
To investigate the bioactivities of fresh garlic and its processed product, black garlic, we conducted comparative analyses of antioxidant, anti-inflammatory, innate immune activation and anti-cancer activities, in addition to chemical composition (sugar, amino acid, polyphenol contents) of these materials. Simultaneous assay using neutrophil-like cells showed that fresh garlic exhibited antioxidant and innate immunostimulatory activities, whereas black garlic displayed a potent anti-inflammatory effect. The antioxidant activity index was correlated with phenol and flavonoid contents, while the innate immunostimulatory activity was correlated with fructan content. Furthermore, some black garlics with low fructose content were found to inhibit the proliferation of UM-UC-3 cancer cells, while other black garlics rich in fructose increased UM-UC-3 cell proliferation. It was shown that the thermal processing steps of fresh garlic could change the composition of sugars, antioxidants, and amino acids, which have different effects on neutrophil-like cells and UM-UC-3 cells, as well as on bioactivities.

26 July 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
HPHardany Primarizky
Hardany Primarizky
SKSatoshi Kambayashi
Satoshi Kambayashi
KBKenji Baba
Kenji Baba
KTKenji Tani
Kenji Tani
MOMasaru Okuda
Masaru Okuda
Lymphoma is the most common neoplasm of lymphoid tissues in dogs. Exportin 1 (XPO1) is an important major nuclear receptor for exporting proteins and RNA species. The XPO1 upregulation can eliminate some tumor suppressor proteins (TSPs) function upon their nuclear–cytoplasmic export. The XPO1 inhibitor, KPT-335, blocks the translocation of TSPs and restores their function to induce cell cycle arrest, apoptosis, and cell proliferation. This in vitro study aimed to evaluate the XPO1 mRNA and protein expression in canine lymphoma cell lines and confirm the relevance with KPT-335. XPO1 mRNA and protein levels were quantified, and the effect of KPT-335 was assessed by a cell proliferation assay. The results indicated that XPO1 mRNA and protein were highly expressed in 17-71, CLBL-1, CLC, CLGL-90, and UL-1, and were moderately expressed in GL-1, Ema, and Nody-1. All canine lymphoma cell lines showed dose-dependent growth inhibition and decreased cell viability in response to KPT-335, with IC50 concentrations ranged from 89.8–418 nM. The expression levels of XPO1 mRNA and protein were related; however, no correlation was found between those expression levels and the efficacy of KPT-335. These findings suggest that XPO1 may represent a promising target for therapeutic intervention in canine lymphoma.